Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPHABET study: Tamsulosin vs vibegron for male lower urinary tract symptoms
jRCT1011230058Not yet recruiting
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tamsulosin and vibegron in overactive bladder (OAB), benign prostatic hyperplasia (BPH) and Micturition disorder (2 arms), sponsored by none. Primary endpoint: OABSS. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
tamsulosinvibegron
03
Conditions
overactive bladder (OAB)benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on jRCT1011230058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011230058.